The purpose of this study was to investigate the validity and reliability evidences of the Omron BI pedometer, which could count steps taken even when worn at different locations on the body. Methods: Forty (20 males and 20 females) adults were recruited to walk wearing 5 sets, 1 set at a time, of 10 BI pedometers during testing, 1 each at 10 different locations. For comparison, they also wore 2 Yamax Digi-Walker SW-200 pedometers and a Dynastream AMP 331 activity monitor. The subjects walked in 3 free-living conditions: a flat sidewalk, stairs, and mixed conditions. Results: Except for a slight decrease in accuracy in the pant pocket locations, Omron BI pedometers counted steps accurately across other locations when subjects walked on the flat sidewalk, and the performance was consistent across devices and trials. When the subjects climbed up stairs, however, the absolute error % of the pant pocket locations increased significantly (P < .05) and similar or higher error rates were found in the AMP 331 and SW-200s. Conclusions: The Omron BI pedometer can accurately count steps when worn at various locations on the body in free-living conditions except for front pant pocket locations, especially when climbing stairs.
The pedometer, a convenient and inexpensive tool for measuring walking, has become increasingly popular in both PA research and promotion. 10, 11 Validity, reliability, and utility of pedometers have been well studied and described in the literature. 10, 12, 13 In general, pedometers can accurately measure walking steps although there could be a large variation among different brands of pedometers and equivalence across devices (ie, crosspedometer consistency) could be a problem sometimes, especially when walking slowly. [14] [15] [16] In addition to the quality of a pedometer (eg, string-levered vs. piezoelectric pedometers 17 ), a few external factors have been found to have an impact on accuracy and consistency of pedometers, including environmental conditions, body composition of wearer and wearing location of the pedometer. Because pedometers measure walking steps in a variety of free-living walking conditions, it is important that a pedometer is able to detect and record steps consistently across different walking conditions. Le Masurier et al 18 compared 3 brands of pedometers in both controlled and free-living conditions and found that there is an inconsistency across the brands in detecting steps in different walking conditions. They therefore called for caution when comparing results across studies when different brands are used and believed that the device accuracy should be presented in absolute terms.
Two factors, wearers' body composition and wearing location of the pedometer, are somewhat related. Pedometers typically are worn on the waistband; although, a few other PA monitors (eg, AMP 331 monitor by Dynastream Innovations and StepWatch by Cyma) are designed to be worn on the ankle. Karabulut et al 19 compared 2 waistand ankle-mounted pedometers and found 11 to 18% cross-monitor inconsistency in recording steps, indicating again, that one must interpret study findings with caution when different monitors/pedometers are used. The major concern of wearing location comes from the impact of body composition since the waistband location sometimes proves less accurate in counting some obese individuals' steps. 12, 17 It is believed that the inaccuracy is caused by excessive abdominal adiposity of some obese individuals, since a belly that hangs over the waistband does not allow a pedometer to be perpendicular to the ground, which is often a requirement of a pedometer based on their internal lever counting design, and the inaccuracy becomes more significant when obese individuals walk at a slow speed. 20 In addition, a belt is usually needed when wearing pedometers at waistband locations.
To overcome the "waist-location only" limitation, Omron Healthcare developed a new pedometer, BI (referring to "Bio Information"), using multiple location sensing technology. The Omron BI, or HJ-720-IT, pedometers can be worn not only at the waist but also at other locations on the body, such as in pockets or in a bag carried close to the body, to count an individual's steps. Basically, 2 piezoelectric acceleration sensors, which generate voltage when they bend, are inside the BI pedometer and an algorithm judges the 2 sensors' outputs on an X-and Y-axis so a true step is determined and counted. If the pedometer can accurately count steps worn in these different locations, it may be easier to measure some obese individuals' PA and also be a more convenient pedometer to use. No study, however, has determined the accuracy and consistency of the Omron BI pedometers by its "multiple-location" feature empirically. The purpose of this study was to assess this need under the new unitary validation framework, 21 in which multiple evidences of validity and reliability, rather than a single type of validity and reliability, are collected and accumulated to provide a sound scientific basis for the proposed score interpretation. For validity evidence, this study examined the step-count accuracy by comparing its results with a known accuracy (ie, steps counted by testers) and step counts recorded by an AMP 331 PA monitor and 2 Digi-Walker SW-200 pedometers. Under the new unitary framework of validation, the former belongs to the "test-criterion relationship" evidence, in which the steps counted by testers served as the criterion, the latter belongs to the convergent evidence, and both of them belong to "evidence based on relations to other variables." 21 For reliability evidence, this study focused on location invariance (ie, cross-location reliability), device equivalence (ie, cross-pedometer reliability) and test-retest reliability. In addition, the impact of both gender and overweightness/obeseness on these findings were examined.
Methods

Subjects
Forty subjects (20 males and 20 females) were recruited from a Midwestern university town through flyers to local fitness clubs, community centers, and churches; through a university's e-mail listserv; and through personal recruitment of colleagues, friends, and acquaintances. A special effort was made to recruit minority participants by making sure recruitment posters were placed in multiracial gathering places, such as the YMCA and local public libraries. Of the 40 subjects, 32 were Caucasians, 3 were African Americans, and 5 were from other minority groups; their mean age (yr), height (cm), and weight (kg) were (M ± SD): 43.55 ± 11.68, 171.45 ± 9.93, and 87.75 ± 20.31, respectively; 9 were in the normal weight BMI category (BMI in kg/m 2 < 25), 14 were in the overweight BMI category (25 ≤ BMI < 30), and 17 were in the obese BMI category (BMI ≥ 30). All subjects provided written informed consent approved by the institutional review board of the university before participation in the study.
Research Design
Subjects were asked to wear Omron BI pedometers and walk in 3 free-living conditions: (1) a flat sidewalk, (2) stairs, and (3) mixed conditions. The focus of Condition 1 was to examine accuracy of the pedometers at different wearing locations. The device equivalence and test-retest reliability of the Omron BI pedometers at these locations and the impact of gender and BMI were examined simultaneously. The focus of Conditions 2 and 3 was to determine if the major findings from Condition 1 can be generalized to other free-living walking conditions. Condition 1: Walk on a Flat Sidewalk. The subjects walked a straight 100 steps on a level concrete sidewalk and performed the 100-step walk 10 times, twice for each set of pedometers, one right after the other. Subjects were told to keep a "steady even pace" to try to replicate their typical walking style. The subjects were allowed to wear any footwear of their choice except for shoes that might affect step count by altering natural walking (eg, sandals or flip-flops). Fifty Omron BI pedometers and 10 SW-200 pedometers were worn and tested in Condition 1. The pedometers were randomly grouped into 5 sets, with 10 Omron BI pedometers and 2 SW-200 pedometers each, and pedometers within each set were further randomly assigned to a specific wearing location described and labeled. Throughout the 10 100-step walks, the subjects wore 10 Omron BI pedometers and 2 SW-200 pedometers, 1 set per 2 walks (back and forth), but the same AMP 331 PA monitor throughout all the walks.
The Omron BI pedometers were worn, or placed, at 10 different locations on the subject's body: 4 at the waist, front left (WFL), front right (WFR), back left (WBL), and back right (WBR) (see locations 1 to 4 in Figure 1) ; 2 in pant's front pockets, left (PL) and right (PR) (locations 5 to 6); 1 in left side shirt pocket (SPL, location 7), 1 inside bag carried on the left side (BL, location 8), 1 around neck as a pendant (NP, location 9), and, finally, 1 in a backpack (BP, location 10). The SW-200 pedometers were placed on the waistband at the front center of that side's leg, left and right, next to the BI pedometers WFL and WFR locations (ie, Locations 1 & 2; with both on the left or right side of BI pedometers). The subjects also wore an AMP 331 activity monitor on their right ankles (Location 11). The locations of these devices are also illustrated in Figure 1 .
Subjects tallied off the 100 steps as they took them with a hand held clicker. A research assistant also followed along behind, so as not to influence the subjects stride length or speed, counting the steps with a clicker also to let the subjects know when to stop. When the subjects reached 100 steps they brought their feet together and stood still while the researcher noted the step counts of the separate pedometers. After the steps were recorded, the research assistant reset the devices or made a note on the last values recorded. The subjects repeated the 100 step walk using the same set of step-count measures to determine the reliability of the devices. After recording the repeated 100 steps, a new set of Omron pedometers (n = 10) and SW-200 pedometers (n = 2) were put on, and the subjects did another 2 100-step walks. This procedure was repeated until all 5 sets of the 10 Omron BIs, and the 5 pairs of SW-200 pedometers were tested. During each testing walk, in addition to the research assistant counting steps, another research assistant timed the 100 step walks of the subject from the first step to the last step using a stopwatch to monitor the walking speed.
Condition 2: Walking Up and Down Stairs. After completion of Condition 1 and a 10-minute break, subjects walked up and down 3 flights of stairs. There were about 80 steps and about 15 m of landings. During the walk, subjects wore the last sets of devices (ie, 10 Omron pedometers, 2 SW-200 pedometers and 1 AMP 331) they wore in Condition 1. The pedometers were reset to 0 at the beginning of this data collection condition. The pedometers recorded step counts while the subjects and a research assistant counted actual steps climbing the stairs. The step counts were recorded at the top of the 3 flights before the subjects descended the stairs. At the bottom of the stairs the pedometer and step counts by the subjects and the research assistant were recorded. Another research assistant timed how long it took subjects to go up 3 flights of stairs and then how long it took them to come back down the stairs.
Condition 3: Walking in a Mixed Situation. Finally, after completion of Condition 2 and another 10-minute break, subjects walked a predetermined guided route, which was about 1253 m (about 1120 m on flat level sidewalks, 51 m on grass, 60 m on a low hill up and down, and 22 m on a ramp in a building from the 1st to the 2nd floor), at their own natural walking speed. A research assistant walked slightly behind the subjects guiding them with verbal cues. During the walk, subjects wore the sets of devices (ie, 10 Omron pedometers, 2 SW-200 pedometers and 1 AMP 331) they wore in Condition 2. The pedometers were reset to 0 at the beginning of data collection Condition 3. The other research assistant timed the free-living walk. At the end of the free-living walk, the research assistants recorded the pedometers' step-counts and stopped the AMP 331 data collection. After completion of all 3 walking conditions, the subjects were paid a small honorarium. 
Data Analysis
After screening and cleaning the data and running descriptive statistics, including examining the normality of key outcome variables using Q-Q plot, Kolmogorov-Smirnov, and Shapiro-Wilk procedures, the data were analyzed to address each condition's focus. For Condition 1, the accuracy of step counting was determined by computing the absolute error %: |R-O|/O × 100%, where R = Recorded steps by a device and O = Observed steps by a tester. The difference between Omron pedometers and other validated monitors was examined using a repeated ANOVA by comparing 2 Omron waist locations (ie, WFR & WFL) with the 2 SW-200 waist locations (ie, SW-200 R & L) and AMP 311 by gender and BMI, respectively. Since the total steps were controlled in Condition 1 (ie, 100 steps in each trial) and between-subject variation did not exist, traditional reliability statistical measures were not appropriate. Therefore, the location invariance, device equivalence, and test-retest reliability of Omron BI pedometers were examined using 3 repeated measure ANOVAs; 1 with 3 within-subject factors (location invariance, device equivalence, and test-retest consistency) and 2 with additional between-subject factor by gender and BMI, respectively.
Validity evidence in Condition 2 was computed a little differently. Since total steps vary among the subjects, the absolute error % now became a relative measure of accuracy (eg, a 10 step difference between recorded and actual steps walked has a different meaning related to a 90 and 100 total steps walked). Therefore, it was also used as an outcome variable for other validity and reliability computations. The differences among the 2 waist Omron pedometers (WFR & WFL) and 2 SW-200 and an AMP311 were examined in the same way as Condition 1 using the absolute error % data of up and down 3 flights of stairs, respectively. For reliability evidence, only location difference was examined using the absolute error % data since device equivalence and test-retest reliability factors were not examined in this condition. To examine the accuracy of a specific (set) location, intraclass coefficients (ICCs) were compared in a "Jackknife" sampling way using the step data, ie, 1 or several devices/locations were excluded in the rotation of the data analysis and their roles to contribute the overall reliability were examined.
Finally, for Condition 3 data, only the convergent validity evidence was computed by comparing the performance of PA monitors using the recorded steps. Reliability evidence was also determined by computing ICCs with different location/device combinations using the recorded steps.
All statistical significant levels were set at .05 and the data analyses were completed using SPSS (version 16). When the sphericity assumption, which was examined by the test of Mauchley, was violated in a repeated measure ANOVA analysis, the Greenhouse-Geisser correction was employed; when the "no group difference" hypothesis was rejected, post hoc group comparisons were followed.
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Results
All step-count data were normally distributed with P = .200 to .991. (Table 2) . However, the SW-200s showed some large mean errors (see Tables 1 ) and SW-L location showed some significant reduction in both accuracy and consistency in both trials (M ± SD: Trial 1 = 83.89 ± 30.53, Trial 2 = 83.33 ± 29.97) when worn by the obese group although the difference was not statistically significant (again all P-values > .05). For reliability evidence using Greenhouse-Geisser correction, no statistical difference was found among these locations (P > .05), across devices (P > .05), and between test-retest trials (P > .05), respectively). Very similar results were found when comparing different gender (P > .05) and BMI groups (P > .05) although the obese group showed a slightly lower accuracy (Table 2) .
Condition 2 accuracy (ie, absolute error %) findings are summarized in Tables 3. On average, about 77 steps were taken when subjects walked up and down the stairs. Except for BP, PR, and PL locations, the Omron pedometers accurately recorded the steps when the subjects walked up the stairs since most of the average absolute errors were under 4%. For the BP location, the overall mean absolute error was 8.15% and male (10.65%), overweight (8.84%), and obese (9.46%) individuals had slightly higher error rates. For PR and PL, the error rates increased significantly, ranging from 9.0% to 27.17%. SW-200s and AMP331 also showed a higher error rate in walking up stairs, ranging from 3.53% to 49.54% (see Table 3 ). When comparing monitors crossly, SW-200R had the highest mean error, followed by SW-200L, WFR, WFL, and AMP331. Statistically (P = .000), SW-200R differed significantly from all others; SW-200L differed from all others except for AMP331, and WFR & WFL differed from all others, but not to each other, and AMP331 differed from all others except for SWL. There was no gender (P > .05) or BMI (P > .05) interactions on the cross-monitor differences, but the "between-subject" factor of BMI was statistically significant (P = .021). The Obese group (M = 20.01, SD = 2.32) had more statistically significant large mean errors than the Normal weight (M = 11.05, SD = 3.19) and the Overweight (M = 11.01, SD = 2.56) groups when comparing the cross-monitor difference. The larger error in the pant pocket locations (PR & PL) also led to an overall statistical difference among locations (P = .000). The post hoc comparisons confirmed that it was the large errors in these locations (PR and PL), which did not differ from each other and the BP location but from all other locations (all P-values < .05), led to the difference. There was an interaction between location and gender (P = .042). The post hoc comparisons found the interaction came from a larger increase in error at the PL location (from the overall mean of 19.87 to the female mean of 27.17). No interaction in BMI was found (P > .05).
For stairs-down errors, Omron pedometers recorded accurately at all locations, with most of the absolute error means below 4% (see also Table 3 ). When comparing monitors crossly, a statistical difference was found (P = .023); the 2 SW-200 had the largest errors and they differed statistically from 2 OMRON pedometers (P = .043 and .048 with WFR and WFL, respectively, Table  3 ). No gender or BMI interaction was observed (P > .05). For reliability evidence, there was no difference among locations (P > .05), neither were there interactions in gender (P > .05) or BMI (P = .05).
The results of ICC based on the stair data are illustrated in Table 4 . ICC based on all 13 devices across 11 locations are listed on the first row by total, gender, and BMI groups, followed by the ICCs of Omron at the 10 locations, then Finally, the consistence in ICC based on Condition 3 data are summarized in Table 5 . About 1,700 steps were walked in this condition. There was no statistically significant difference among locations (P > .05); neither were there gender (P > .05) or BMI (P > .05) interactions. No difference was found when monitors crossly (P > .05) were compared, although SW-200R and AMP331 showed slightly lower means and SW-200L showed an obviously lower mean in the Obese group. ICCs support the above observation: ICCs decreased when Omron pedometers were deleted and ICCs either increased or only slightly decreased when other PA monitors were deleted.
Discussion
Promoting physical activity in a population using simple and effect methods has become a national health imperative and walking is definitely one of the best PA choices. To be able to accurately count steps walked is therefore essential for walking behavior assessment and evaluation. While many different types of walking monitoring devices have been developed and can be worn on the waist, the ankle, the wrist, and the upper arm, pedometers, which are usually less than $30, are the most commonly used device in both research and practice. Almost all the pedometers in the past, however, were designed to be worn at the waist, which created some inconvenience when a person does not wear a belt or clothing with a waistband at their natural waist. Furthermore, studies have shown that some obese individuals may have inaccurate pedometer step counts when pedometer is worn at the waist location. 12, 17, 20 Using new technology, the Omron BI pedometer is the first pedometer designed to be worn at different locations on the body. With a new validation framework, evidence of Omron BI pedometers' validity and reliability across different locations was collected and evaluated.
Overall, the accuracy and location invariance of Omron BI pedometers are well supported by the findings of this study. Except for a slightly decreased accuracy in the pant pocket locations, the step counts at all other locations were very accurate when subjects walked on a flat sidewalk. This observation was further confirmed when compared with 2 validated PA monitors, in which the Omron BI pedometers showed similar or better accuracy. The device equivalence and test-retest reliability were satisfactory, with little difference in performance between different sets of devices and test and retest trials. In addition, the findings can be generated to different gender and BMI groups, but the sample sizes by these subgroups are small.
The findings were able to generalize to 2 other tested walking conditions: stairs and mixed free-living. A significant increase in errors by the 2 pant pocket locations in the stairs-up condition, however, was noticed. This is somewhat expected since legs, especially thighs, have to lift high when climbing stairs, which has a different movement signature to the pedometers in the pant pocket locations. It seems the current internal design of the Omron BI was not be able to detect a stairs-up walking pattern well when they were put into pant pockets. Omron BI pedometers should not be put in pant pockets for step counts and future versions of Omron pedometers should either overcome this design limitation or not recommend this placement location. A large error in the stairs-up condition was also observed in the 2 comparison monitors (ie, SW-200 and AMP 331). Surprisingly, the errors in the stair walking condition have not been fully recognized according to a comprehensive literature search. Except for a few attempts (eg, Schmalzried et al 23 ), large pedometer errors in stair walking conditions were rarely mentioned. Considering climbing stairs has often been recommended in promoting walking, future PA research and promoting need to take into consideration the large errors of commonly used walking monitors.
Except for the pocket locations, Omron BI pedometers showed a satisfactory performance when measuring BMI determined overweight or obese individuals. In Table 1 Step counts WFR 100. Counter 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.02 ± 0.20 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.02 ± 0.22
Error % WFR Note. Total = all subjects.
general, there is little difference between different BMI groups across the wearing locations. They were all able to provide an accurate count of steps taken. This study also demonstrated an example of how the quality of a walking device should be evaluated. Validity and reliability evidences of a device is evaluated often by an inappropriate research design, in which errors and variances of a device and subjects' PA behavior change are mixed up, or by an inappropriate statistical index. As a result, the meaning of the finding is often limited or even sometimes misleading. As an example, when studying the "reliability" of physical activity monitors, researchers in many published studies often asked subjects to wear a monitor for a number of days or a week and then after a short or long-term interval, to wear the monitor again for the same length period. The test-and-retest data were then used to compute the reliability of the monitor. Since the device reliability in this kind of research design is confounded with subjects' stability of physical activity participation, there is no way to determine the true reliability of the monitor. Furthermore, since most of between-time differences are the variation of subjects' PA behavior, the reported device reliability is indeed mainly the stability of subjects' physical activity behaviors. This kind of reliability is not device/instrument reliability, but rather "score reliability." 24 By adapting a new unitary validation framework, this study employed a different way to collect and evaluate validity and reliability evidence. Under this new framework, to-be-collected multiple evidences are first clearly defined; then a research study with these evidences in mind is designed; finally, appropriate statistical analyses are applied and specific evidences are labeled and interpreted. As an example, we believe that types of reliability evidence must be clearly operationally defined in a research study. In general, instrument reliability and person stability should be distinguished and, where there is a need, further breakdowns should be included. In our study, "location invariance," "device equivalence," and "test-retest trial reliability" are further defined to distinguish different aspects of the instrument reliability. Measurement specialists in exercise science 25, 26 have long called for distinguishing the error variances in a reliability study and determine the impact of the variances using more advanced reliability theory and methods, such as generalizability theory. Unfortunately, these recommendations have been basically ignored in most reliability research studies. With a careful research design, a specific type of validity and reliability evidence can be examined at the same time. Using a 3-walking condition design, for example, accuracy or validity and reliability (ie, location invariance, device equivalence and test-retest reliability) of the Omron BI pedometers, as well as the gender and BMI impact, were examined and evaluated in different walking conditions simultaneously in this study.
This study also illustrated how a statistical index should also be carefully selected and labeled. In physical activity research, a statistical index has often been inappropriately selected and labeled. Using reliability again as an example, the Pearson correlation coefficient is often incorrectly used to compute reliability and the same term "reliability" is often applied to all kinds of situations even if different "reliability" aspects of a test or score are investigated. The consequence of this kind of "over-generalization" practice is that the reader may be misled about the true meaning of a research finding. In contrast, since several different kinds of reliability were examined in this study, they were purposely labeled with different terms: "location invariance," "device equivalence," and "test-retest reliability," respectively. Since all subjects walked 100 steps in Condition 1, between-subject variance no long existed. As a result, ICC or similar commonly used reliability statistics were no longer appropriate. Therefore, repeated-measures ANOVA method was employed to address the issues. Because the between-subject variances were brought back in Conditions 2 and 3, ICC were also employed along with the ANOVA analyses. Future PA device validation studies should be designed, analyzed, and reported under the new unitary validation framework.
It should be acknowledged that the findings of this study were based on the "typical" walking speed of subjects and should not be generated to other walking speed conditions. Furthermore, the sample size employed in this study was relatively small even though BMI range was large. Finally, the performance of the Omron BI pedometers in the mixed condition was not compared with a criterion measure, but to other validated devices. Future studies of the Omron BI pedometers should address these limitations.
Conclusion
In conclusion, the newly developed Omron BI pedometer can accurately count walking steps when worn at various locations on the body although it was less accurate for the 2 pant pocket locations. The Omron BI pedometer also demonstrated a high device equivalence and testretest reliability. In addition, the Omron BI pedometer demonstrated a similar or better performance than 2 commonly used walking monitors validated PA monitors compared, but both Omron BI pedometer pocket locations and 2 other walking monitors showed a high error rate in the stair climbing condition, indicating the data should be interpreted with caution when stair climbing is frequently included. The study also illustrated how a PA device should be validated under the new, unitary validation framework. Future studies should extend the testing to other walking speeds, with large sample sizes and a criterion measure that can measure specific steps taken in the "mixed" conditions. Efforts should also be made to develop new pedometers that can eliminate errors in the stair climbing condition.
